Improving the lives of Canadian children
and youth with rare diseases
Improving the lives of Canadian children<br><span class='text-2xl md:text-3xl xl:text-4xl'>and youth with rare diseases</span>

CPSP News

CPSP: Call for study proposals

The Canadian Paediatric Surveillance Program (CPSP) is looking for investigators to initiate new studies for active surveillance of low-frequency, high-impact diseases and conditions that affect Canadian children and youth. Interested investigators should contact the CPSP to discuss topics of interest and to submit their proposals before September 1, 2024 for consideration at the Fall CPSP Scientific Steering Committee meeting.

Hyperglycemic Hyperosmolar State

Hyperglycemic hyperosmolar state (HHS), an acute complication of type 2 diabetes that stems from a relative deficiency in insulin.  The CPSP launched a new study on June 1, 2023 to determine the populations most at risk for and precipitating factors of HHS in childhood, and gather data to inform guidelines on the presentation, management, and rates of complications of HHS in children. For more information, please visit our website.

Electronic Reporting Option
Sign up for monthly electronic
reporting today
ADR Tips

ADR Tips

Find out timely tips on adverse drug reactions reported to the CPSP and Health Canada.

Annual Results

Annual Results

Results pertaining to studies and surveys are published annually.

CPSP Studies

CPSP Studies

The CPSP facilitates studies in a variety of fields, such as infectious diseases, congenital and genetic diseases, injury prevention and mental health. View lists of current studies and concluded studies.